alexa Using Small Molecule Estrogen Receptor Biomodulators To Identify New Pathways And As Anticancer Drugs | 22186
ISSN: 2161-1017

Endocrinology & Metabolic Syndrome
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

2nd International Conference on Endocrinology
October 20-22, 2014 DoubleTree by Hilton Hotel Chicago-North Shore, USA

David J Shapiro
Accepted Abstracts: Endocrinol Metab Synd
DOI: 10.4172/2161-1017.S1.007
Abstract
Estrogens, acting via estrogen receptor (ER), stimulate cell proliferation, and tumor growth. Endocrine therapy targeting these tumors using aromatase inhibitors to inhibit estrogen production, and tamoxifen and other antiestrogens that compete with estrogens for binding to ER, is a mainstay in breast cancer treatment. Selection and outgrowth of resistant tumors is common. Screening identified a lead non-competitive ER inhibitor. At sub-micromolar concentrations, the inhibitor blocked proliferation of ER positive breast, ovarian and endometrial cancer cells-including cells resistant to tamoxifen and Fulvestrant/Faslodex/ICI 182,780. The compound had no effect in ER negative cells. In a mouse xenograft model, the inhibitor was not toxic and induced rapid and substantial tumor regression. This unusual ER inhibitor is so effective because it targets multiple pathways. Independent of its other effects, the compound rapidly inhibits estrogen-ER induction and repression of gene expression. Chromatin immunoprepcipitation (ChIP) shows the compound inhibits recruitment of ER to regulatory regions of estrogen responsive genes. The compound also acts outside the cell nucleus to regulate pathways not previously linked to ER action. Subsequent investigation revealed that the inhibitor distorts and amplifies a previously undesribed action of estrogen and ER, leading to death of the ER containing cancer cells. Our studies demonstrate the potential of targeted cellbased screening to reveal new pathways of action, coregulators and small molecule therapeutic candidates; even in a system as intensively studied as ER positive cancer. Supported by NIH DK-017909.
Biography
David J Shapiro received his Ph.D. from Purdue University, did postdoctoral work at Stanford University School of Medicine and was a Guggenheim Fellow in the Center for Cancer research at MIT. He is the author of more than 100 research papers and book chapters in the field of steroid hormone receptor action and has served on the Editorial Boards of the Journal of Biological Chemistry (JBC), Molecular Endocrinology and other journals. Most current research focuses on identification and characterization of novel steroid receptor biomodulators; using biomodulators to identify previously undescribed pathways and evaluating them as anticancer drugs.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version